The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Pharmaceuticals

URL:  http://boards.fool.com/jmp-securities-has-increased-target-from-7-to-28485747.aspx

Subject:  Re: Ziopharm Date:  5/3/2010  2:15 PM
Author:  Smufty2 Number:  871 of 892

JMP securities has increased target from $7 to $10.
Report not yet public.
Interesting thing is that JMP is only assigning value to one of the programs. This leaves a lot of room to the upside as the clinical trials progress in the other two.


Smufty
Copyright 1996-2014 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us